Extrahepatic Cholangiocarcinoma — Trials

Extrahepatic Cholangiocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

98 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 29
Recruiting: 19
Ph III recruiting: 1
Growth YoY: —
Industry share: 3%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (10)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03768414	Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers	completed	Phase 3	452	SWOG Cancer Research NetworkNETWORK	1	Jan 12, 2026	clinicaltrials

Data updated 23 days agoSource updated Jan 12, 2026source: clinicaltrials